A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

BACKGROUND: Currently, the clinical strategy for diagnosis of non-muscle invasive bladder cancer (NMIBC) such as cystoscopy and cytology are invasive and/or with limited accuracy. OncoUrine, a urinary assay for mutation and methylation biomarkers, have showed a high accuracy in the detection of uppe...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hai, Liu, Ao, Liang, Yiming, Xin, Yaqun, Liu, Jiacheng, Hao, Yining, Huang, Da, Chen, Lu, Li, Wei, Jiang, Guangliang, Huang, Yuhua, Xu, Yaoting, Zhang, Jie, Ma, Tonghui, Xu, Danfeng, Gao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510256/
https://www.ncbi.nlm.nih.gov/pubmed/37726806
http://dx.doi.org/10.1186/s12916-023-03065-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510256/
https://www.ncbi.nlm.nih.gov/pubmed/37726806
http://dx.doi.org/10.1186/s12916-023-03065-5

Ejemplares similares